Twitter Buys Gnip to Monetize Data; Johnson & Johnson Beats Analysts’ Expectations

Follow this company

Companies Mentioned

04/16/2014 [ACCESSWIRE]

Twitter, Inc. (NYSE: TWTR) – For an in-depth report on Twitter, Inc. follow:

Shares of Twitter closed up 11.38% on Tuesday with about 24.2 million shares traded. The stock was one of the biggest gainers on the NYSE as well as one of the most active. The company has bought Gnip, which provides analysis of the more than 500 mil daily tweets to advertisers and companies, including IBM and Microsoft. Terms weren't disclosed. The company plans to leverage Gnip's technology in new data analysis products.

Groupon, Inc. (NASDAQ: GRPN) - For an in-depth report on Groupon, Inc. follow:

Shares of Groupon closed up about 2% on Tuesday with nearly 18 million shares traded. The company had no significant news but is intending to hold a conference call to discuss its first quarter 2014 financial results on Tuesday, May 6, 2014, at 5:00 p.m. EDT.

GreenGro Technologies, Inc. (OTC: GRNH) - For an in-depth report on GreenGro Technologies, Inc. follow:

Shares of GRNH closed down 17.24% on Tuesday with about 4.4 million shares traded. The stock was one of the biggest decliners in the OTC marketplace. Last week the company announced the official grand opening of its Anaheim California store on May 15th. The Vertical Hydrogarden store soft opened this month with some 30,000 product offerings on shelves around the store. The Anaheim store is the second location with continued Company expansion plan to reach 50 stores openings.

Johnson & Johnson (NYSE: JNJ) – For an in-depth report on Johnson & Johnson follow:

Johnson & Johnson closed up about 2% on Tuesday with about 14 million shares traded on Tuesday. The company beat Wall Street expectations and raised its earnings outlook. Johnson & Johnson said that net income was $4.73 billion, or $1.64 per share, up from $3.5 billion, or $1.22 per share, a year earlier. Excluding one-time items, income was $4.43 billion, or $1.54 per share. Analysts expected $1.48.


Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.


Leave a comment...

Your Name